Login to Your Account



Troubling Transition: Alzheimer's drug appears safe, but not so effective

By Michael Fitzhugh
Staff Writer

Wednesday, June 24, 2015
A phase II/III study of Transition Therapeutics Inc.'s lead neuropsychiatric drug, ELND005 (scyllo-inositol), found it about as good as a placebo in reducing the agitation and aggression that often surfaces in people with Alzheimer's.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription